Trial of vitamin D to reduce risk and severity of COVID-19 (CORONAVIT).
Adrian Martineau, Professor of Respiratory Infection & Immunity at Queen Mary University of London, discusses his research trial, CORONAVIT, on vitamin D to reduce risk and severity of COVID-19, including challenges, recruitment, ethical considerations, data collection and analysis, and using th...
| Other Authors: | |
|---|---|
| Format: | Video |
| Language: | English |
| Language Notes: | Closed-captioned in English. |
| Published: |
London :
SAGE Publications, Ltd.,
2021.
|
| Subjects: | |
| Online Access: | Connect to this streaming video |
| Summary: | Adrian Martineau, Professor of Respiratory Infection & Immunity at Queen Mary University of London, discusses his research trial, CORONAVIT, on vitamin D to reduce risk and severity of COVID-19, including challenges, recruitment, ethical considerations, data collection and analysis, and using the Trials Within Cohort research design. |
|---|---|
| Physical Description: | 1 online resource (1 video file (00:13:51)) : sound, colour |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 1529781507 9781529781502 |